Drug · DIN 02541769
EVKEEZA
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 21, 2023; first marketed November 21, 2023.
- Drug Identification Number (DIN)
- 02541769
- Company (DIN owner)
- Ultragenyx Pharmaceutical IncNovato, California, United States
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Evinacumab C10AX17
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EVINACUMAB | 150 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 22, 2023: NOC 31701New Drug Submission (NDS)